Flexibility designed for emerging biotech

The world of drug development is rapidly changing, driven by the dramatic evolution of technology and science, and now the impact of a global pandemic. As innovative biotech companies continue to fill the pipeline, IQVIA Biotech is here to help them succeed.

IQVIA Biotech delivers flexible clinical development solutions designed to help biotech and emerging biopharma companies move forward in their effort to get treatments to patients. When you partner with our clinical operations team, you gain expertise from two decades of planning and running clinical trials exclusively for biotech companies. We understand the unique challenges, hurdles, and opportunities you face. From plan development to trial design and execution, we draw on this experience to put together the right solution, and the right team, for you.

For more information, visit our website and follow us on LinkedIn and Twitter.



IQVIA Biotech

2400 Ellis Road

Durham, NC 27703


Phone: +1-910-200-1845

Contact: Daniel Halligan


  • IQVIA Biotech was approached by a clinical-stage biopharmaceutical company to run its Phase II prostate cancer drug trial in the U.S. For more information, download the available case study.

  • IQVIA Biotech was selected to help a U.S. biopharmaceutical company examine the safety and efficacy of its investigational therapy for the treatment of moderate-to-severe hidradenitis suppurativa (HS), a chronic skin condition that causes small, but painful lumps under the skin. This case study will highlight IQVIA Biotech’s unique strategies for site selection and centralized recruitment approach to drive enrollment.

  • A biologics company needed a CRO with oncology experience that could support protocol design and accelerate the start-up process to meet a quick first-patient-in (FPI) milestone. In this case study, discover how this partner evaluated the safety and pharmacokinetic (PK) profile of an immunotherapeutic drug in subjects with advanced solid tumors.

  • Learn how IQVIA Biotech helped a biotechnology company reach critical milestones as it prepared to launch an international Phase III clinical trial for its investigational ALK inhibitor in patients with non-small cell lung cancer.

  • Read how this RFP planning guide helps oncology sponsors identify key cost drivers, save time, and make planning easier, while navigating clinical outsourcing, with timeline and financial considerations in mind.

  • This short video explains how and why business process outsourcing (BPO) using IQVIA Technologies for site payments offers excellent ROI for sponsors and peace of mind for sites and investigators.